Blocking cancer metastasis with TGF-beta antagonists
Lu Zhe Sun
François M. Vallette
Jin Gao, Jingjing Quan, Chuanxiang Zhou and Glenn Francisg
Caterina La Porta
Deconstructing Cancer Progression: Cancer Stem Cells and Dedifferentiation
Carlos F. D. Rodrigues
Stat5: from lactogenesis to tumorigenesis
Itamar Barash
Inflammatory chemokines in breast cancer: Regulation by genetic and host factors
Adit Ben-Baruch
Chun Tu
Individual chemosensitivity test for personalized therapy in cancer patients
Jianping Gong, Dong dong Yu and Jichao Qin
Tanshinone IIA on apoptosis via SAPK/JNK signal transduction in pancreatic cancer cells
Peihao Yin
The anti-tumor effect of fermented curcumin
Ha-rim Choi, Hyung-Sik Kang and Youn-Tae Chi
Involvement of extracellular proteases ADAM17 and ADAM10 in germ cell apoptosis induced by etoposide
Ricardo D Moreno
Prakash Radhakrishnan and Michael A Hollingsworth
John E. Thompson, Catherine Taylor and Richard Dondero
The MAGE protein family: Protein degradation, genome stability, and cancer
P. Ryan Potts
GATA4 represses ERBB2 expression in cancer cells : a new tumor suppressor?
Jean IMBERT
GUC as potential DNA topoisomerase inhibitors to reduce the growth of cervical cancer cells
Hassan Hadi Abdallah, Mohammad T.M Al-dajani, Jamal Talaat, Akeem Akiboro, Khoo Boon Yin and Nornisah Mohamed
Tine D. Rasmussen, Louise Linnebjerg Bohn Christoffersen, Olaf-Georg Issinger
Yi-Ching Wang
Prognostic utility of BRAF mutation in thyroid cancer
Mingzhao Xing
New biomarkers of cancer vaccine research
Jeffrey C. Gildersleeve
Dongfeng (Dan) Tan
Season-of-Birth as a prognostic factor of survival time follow a diagnosis of cancer
Jimmy T. Efird
Biomarkers for therapy with the EGFR inhibitors
Helmout Modjtahedi
Lars Henrik Jensen
Tumor specific oligomeric forms of protein b23/nucleophosmin
N.M.Vladimirova
M. H. Bukhari
Gold Nanoparticles and Nanotechnology for Cancer Biomarker Discovery and Research
Qun Huo
Simon Fredriksson
Combination of Notch1 and Notch2 as Prognostic Marker on Patients with Colorectal Cancer
Dake Chu
Methylation biomarkers – From discovery to clinical use
Tomasz K Wojdacz
Ali S. Alshehri and Hafez E.E
Novel Role for orphan receptor PXR in Cancer
Sridhar Mani
DynaCT as a new tool for onsite and realtime navigation in the lung
Wolfgang Hohenforst-Schmidt
DynaCT as a new tool for onsite and realtime navigation in the lung
Wolfgang Hohenforst-Schmidt
Individualized chemo-radiation therapy based on quantitative functional imaging
Dag Rune Olsen
Targeting EGFR for fluorescence optical imaging of cancer
Haibiao Gong
Agnieszka Trojanowska
Digital imaging in mammography helping enhancing the detection & diagnosis of breast lesions
Bhawna Dev
The mechanism & causes of carcinogenesis and mutagenesis in eukaryotes
Stephen W.J. Wang
Bioactive Compounds for Cancer Prevention
Jaime A Yanez
Beyond the Pyramid: Diet and Alternative Compounds for Cancer Prevention
Jeffery G. Herman
Alina Barnett
Yves-Jean BIGNON
Ann E. Fonfa
Preventive medicine: Hope or Hype?
Amr Amin
Cancer and palliative care in Africa: Case of Cameroon
Koanga Mogtomo ML and Ngono Ngane RA
Anna Enblom and Kristin Campbell
Paul J. Higgins
Molecular targets of cardiac hormones in cancers
David L. Vesely
Mechanical blocking of cancer cell division by progerin
Olga Moiseeva
The transcriptional landscape of nasopharyngeal carcinoma defined by RNA-seq
Mu-Sheng Zeng
Nanoformulated nanocarriers with modified lactoferrin for cancer and bio-distribution through MRI
Jagat R. Kanwar, Rupinder Kanwar and Ganesh Mahidhara
Alternative splicing of Kruppel-like factor 4 plays a role in colorectal tumorigenesis
Seung J. Baek and Jae Hoon Bahn
Zhiyuan Zhang, Qin Xu, Xiuming Liu and Wantao Chen
Peptide-Targeted Chemotherapy against Breast Cancer
Chin-Tarng Lin
Zamecnikova Adriana
Microtubule: A target for withaferin-a induced cell death
Sumita Sengupta, Kamalini Ghosh, Amlan Das, Ansuman Lahiri and Gopal Chakrabarti
Molecular basis of anti-inflamatory strategies in cancer cachexia
Marilia Seelaender
Adenovirus Library for Novel Transductional Targeting
Yamamoto Masato
Magnetic Resonance Imaging Guided Thermal Ablation for Cancer
Sherif G. Nour
Molecular cancer therapy via modulating autophagy
Liang Xu
Pathobiology and prevention of bone Loss caused by cancer chemotherapy
Cory J Xian
What is the optimal treatment for metastatic colorectal cancer?
Esther Uña Cidón
Xiao-Feng Sun
Stefano Scabini, Edoardo Rimini, Andrea Massobrio, Emanuele Romairone, Renato Scordamaglia and Valter Ferrando
Manoj Kumar B
Acute or subacute cor pulmonale: When should we look for malignancies?
Raniero Di Giovambattista
Aliakbar Taherian and Tahereh Mazoochi
Benjamin Sredni, Adi Bazar and Yona Kalechman
Intratumoral chemotherapy (ITC) as adjunct to standard therapy in NSCLC iiia-iv prolongs life
Wolfgang Hohenforst-Schmidt
Eugene P. Goldberg, Wolfgang Hohenforst-Schmidt and Seyhan Celikoglu
Extra cellular matrix derived endogenous angioinhibitor tumstatin and its mechanism(s) of action
Sudhakar Akul
The association between Charlson Comorbidity Index(CCI) and the burden of cancer
Eun-Jung Kim
Therapeutics and Toxicology of Liposome-Based Anticancer Drugs
Alberto A. Gabizon
Karl Kingsley and Deidre Turner
Molecular basis of anti-inflamatory strategies in cancer cachexia
Martins Thomas
Nose bleed gone wild: Extramedullary plasmacytoma of the right nasal septum
Erwin Jannino O. Ybanez
Evaluation of dendritic cells and RANTES in patients suffering from ovarian cancer
Jan Kotarski, Iwona Wertel and Wanda Rogowska
Cancer-Relevant Functions of the Plasma Membrane Receptor for Thyroid Hormone Analogues
Paul J. Davis, Hung-Yun Lin, Vivian Cody, Faith B. Davis, Aleck Hercbergs and Shaker A. Mousa
Ribophorin II (RPN2) as a novel therapeutic target for cancer stem cells
Takahiro Ochiya
Chulso Moon
Analysis of miR-195 and miR-497 expression, regulation and role in breast cancer
Dan Li, Yulan Zhao, Changxing Liu, Xiaona Chen, Yanting Qi, Yue Jiang, Chao Zou, Xiaolong Zhang, Shunying Liu, Xuejing Wang, Chuan-Xiu Bian, Dan Zhao, Qiang Sun, Zhenbing Zeng, Andreas Dress, Marie C. Lin, Hsiang-Fu Kung, Feng Mao, Bing- Hua Jiang and Lihui Lai
Multifunctional nanoparticles for targeted drug delivery and mri contrast agent
P.Pramanik
Targeting superoxide dismutase 1 for chemosensitization of platinum resistant ovarian cancer cells
Mu Wang
Unresolved inflammation: Immune dynamics of aging process and tumorigenesis
Mahin Khatami
IPMN of the pancreas - Evaluation of pathohistological subtypes and clinical outcome
Marius Distler
Mohammad Mehdi Soltan Dalla, Mohammad Hossein Yazdi, Marzieh Holakuyee, Zuhair Mohammad Hassan, Abbas Mirshafiey and Mehdi Mahdavi
Jianshi Lou, Jing Zhu and Zhiqing Cui
BiTE Antibodies for Cancer Therapy
Patrick A. Baeuerle and Roman Kischel
Miroslaw J. Szczepanski
Miroslaw J. Szczepanski
Miroslaw J. Szczepanski
Targeted and image-guided cancer treatment using Theranostic nanoparticles
Lily Yang
Carol Bernstein
Mutagenesis of p53 by reactive PAH and ROS
Jeffrey Field
Variability in carcinogen metabolism
Mohamadi Sarkar
Francesco Recchia
Mutagenesis as a biomarker of risk areas for carcinogens: Human biomonitoring
Vargas V M F, Coronas M V, Pereira T S, Rocha J V, Rodrigues ML, Fachel J, Faccini L S, Thiesen F, Nussbaumer L, Oliveira S Dapper V and Salvadori D M F
Carcinogenic human papillomavirus (HPV) in suburban U.S. female population
Sin Hang Lee
The ‘tether drop’ hypothesis for the mechanism of chromosomal aberrations
Leon P. Bignold
Stephanos Pavlides
Qi Li
Marta Szajnik
The mechanism & causes of carcinogenesis and mutagenesis in eukaryotes
Shaukat Iqbal Malik
Gary Guishan Xiao
Katharina Pachmann
Bifidobacterium Infantis on Lewis lung cancer in mice
Hong Zhu, Zhaojun Li, Shuhua Mao, Buyun Ma, Shengtao Zhou, Licong Deng, Taiguo Liu, Dandan Cui, Yaqin Zhao, Jianping He, Cheng Yi and Ying Huang
Xu Man, Wang Yuqi, Xu Guangxu, Geng Weipu and Tang Junying
Shukla Piyush
Functional genomics to identify cancer targets
William C. Hahn
The anti-tumor role of gene UBTD1 and a positively regulatory loop between UBTD1 and p53
Xiaowei Zhang, Jin Li and Weijian Guo
R.K. Srivastava, S-N. Tang, M. Rodova, D. Nall and S. Shankar
Eldad Zacksenhaus
Lilian Jara
Pharmacogenomics predictions for breast cancer treatments? efficacy and toxicity
Hugo A. Barrera-Saldana
A novel feedback loop with therapeutic implications in estrogen receptor-negative breast cancer
Ali Naderi
M. H. Bukhari
Combining biologics and cytotoxics in the treatment of inoperable cholangiocarcinoma
Lars Henrik Jensen
Stability analysis on liver cancer related miRNA in Serum
DING Xian-Feng, LI Yan and GUO Jiang-Feng
The status of anti-metastatic gene therapy in patients with advanced epithelial ovarian cancer
Samir A. Farghaly
M Ziman, M. Millward, R. Pearce, M. Lee, P. Kumarasinghe and A. Ireland
Sissi C. Stove Lorentzen, Ingunn Bergstad, S.Gharagozlian
Waseem Hassan
Blocking cancer metastasis with TGF-beta antagonists
Lu Zhe Sun
Francois M. Vallette
Jin Gao, Jingjing Quan, Chuanxiang Zhou and Glenn Francis
Caterina La Porta
Deconstructing Cancer Progression: Cancer Stem Cells and Dedifferentiation
Carlos F. D. Rodrigues
Stat5: from lactogenesis to tumorigenesis
Itamar Barash
Inflammatory chemokines in breast cancer: Regulation by genetic and host factors
Adit Ben-Baruch
Chun Tu
Individual chemosensitivity test for personalized therapy in cancer patients
Jianping Gong, Dong dong Yu and Jichao Qin
Tanshinone IIA on apoptosis via SAPK/JNK signal transduction in pancreatic cancer cells
Peihao Yin
The anti-tumor effect of fermented curcumin
Ha-rim Choi, Hyung-Sik Kang and Youn-Tae Chi
Involvement of extracellular proteases ADAM17 and ADAM10 in germ cell apoptosis induced by etoposide
Ricardo D Moreno
Prakash Radhakrishnan and Michael A Hollingsworth
Prognostic utility of BRAF mutation in thyroid cancer
Mingzhao Xing
New biomarkers of cancer vaccine research
Jeffrey C. Gildersleeve
Dongfeng (Dan) Tan
Biomarkers for therapy with the EGFR inhibitors
Helmout Modjtahedi
Tumor specific oligomeric forms of protein b23/nucleophosmin
N.M.Vladimirova
M. H. Bukhari
Simon Fredriksson
Methylation biomarkers - From discovery to clinical use
Tomasz K Wojdacz
Season-of-Birth as a prognostic factor of survival time follow a diagnosis of cancer
Jimmy T. Efird
Lars Henrik Jensen
Gold Nanoparticles and Nanotechnology for Cancer Biomarker Discovery and Research
Qun Huo
Combination of Notch1 and Notch2 as Prognostic Marker on Patients with Colorectal Cancer
Dake Chu
Novel Role for orphan receptor PXR in Cancer
Sridhar Mani
DynaCT as a new tool for onsite and realtime navigation in the lung
Wolfgang Hohenforst-Schmidt
Individualized chemo-radiation therapy based on quantitative functional imaging
Dag Rune Olsen
Targeting EGFR for fluorescence optical imaging of cancer
Haibiao Gong
Agnieszka Trojanowska
Digital imaging in mammography helping enhancing the detection & diagnosis of breast lesions
Bhawna Dev
Yves-Jean BIGNON
Ann E. Fonfa
Preventive medicine: Hope or Hype?
Amr Amin
Cancer and palliative care in Africa: Case of Cameroon
Koanga Mogtomo ML and Ngono Ngane RA
Anna Enblom and Kristin Campbell
Stephen W.J. Wang
Bioactive Compounds for Cancer Prevention
Jaime A Yanez
Bioactive Compounds for Cancer Prevention
Jaime A Yanez
Beyond the Pyramid: Diet and Alternative Compounds for Cancer Prevention
Jeffery G. Herman
Alina Barnett
Paul J. Higgins
Molecular targets of cardiac hormones in cancers
David L. Vesely
Beta-glucans as anticancer agents
Anshu Agrawal, Sudhanshu Agrawal and Sudhir Gupta
Mechanical blocking of cancer cell division by progerin
Olga Moiseeva
The transcriptional landscape of nasopharyngeal carcinoma defined by RNA-seq
Mu-Sheng Zeng
Nanoformulated nanocarriers with modified lactoferrin for cancer and bio-distribution through MRI
Jagat R. Kanwar, Rupinder Kanwar and Ganesh Mahidhara
Alternative splicing of Kruppel-like factor 4 plays a role in colorectal tumorigenesis
Seung J. Baek and Jae Hoon Bahn
Zhiyuan Zhang, Qin Xu, Xiuming Liu and Wantao Chen
Peptide-Targeted Chemotherapy against Breast Cancer
Chin-Tarng Lin
Zamecnikova Adriana
Microtubule: A target for withaferin-a induced cell death
Sumita Sengupta, Kamalini Ghosh, Amlan Das, Ansuman Lahiri and Gopal Chakrabarti
Molecular basis of anti-inflamatory strategies in cancer cachexia
Marilia Seelaender
Adenovirus Library for Novel Transductional Targeting
Yamamoto Masato
Magnetic Resonance Imaging Guided Thermal Ablation for Cancer
Sherif G. Nour
Molecular cancer therapy via modulating autophagy
Liang Xu
Pathobiology and prevention of bone Loss caused by cancer chemotherapy
Cory J Xian
What is the optimal treatment for metastatic colorectal cancer?
Esther Una Cidon
Xiao-Feng Sun
Stefano Scabini, Edoardo Rimini, Andrea Massobrio, Emanuele Romairone, Renato Scordamaglia and Valter Ferrando
Intensity modulated radiotherapy in chemoreduced retinoblastoma
Aman Sharma
Manoj Kumar B
Acute or subacute cor pulmonale: When should we look for malignancies?
Raniero Di Giovambattista
Aliakbar Taherian and Tahereh Mazoochi
Benjamin Sredni, Adi Bazar and Yona Kalechman
Intratumoral chemotherapy (ITC) as adjunct to standard therapy in NSCLC iiia-iv prolongs life
Wolfgang Hohenforst-Schmidt
Eugene P. Goldberg, Wolfgang Hohenforst-Schmidt and Seyhan Celikoglu
Extra cellular matrix derived endogenous angioinhibitor tumstatin and its mechanism(s) of action
Sudhakar Akul
The association between Charlson Comorbidity Index(CCI) and the burden of cancer
Eun-Jung Kim
Therapeutics and Toxicology of Liposome-Based Anticancer Drugs
Alberto A. Gabizon
Karl Kingsley and Deidre Turner
Molecular basis of anti-inflamatory strategies in cancer cachexia
Martins Thomas
Nose bleed gone wild: Extramedullary plasmacytoma of the right nasal septum
Erwin Jannino O. Ybanez
Evaluation of dendritic cells and RANTES in patients suffering from ovarian cancer
Jan Kotarski, Iwona Wertel and Wanda Rogowska
Hari K Koul
Cancer-Relevant Functions of the Plasma Membrane Receptor for Thyroid Hormone Analogues
Paul J. Davis, Hung-Yun Lin, Vivian Cody, Faith B. Davis, Aleck Hercbergs and Shaker A. Mousa
Ribophorin II (RPN2) as a novel therapeutic target for cancer stem cells
Takahiro Ochiya
Chulso Moon
Analysis of miR-195 and miR-497 expression, regulation and role in breast cancer
Dan Li, Yulan Zhao, Changxing Liu, Xiaona Chen, Yanting Qi, Yue Jiang,, Chao Zou, Xiaolong Zhang, Shunying Liu, Xuejing Wang, Chuan-Xiu Bian, Dan Zhao, Qiang Sun, Zhenbing Zeng, Andreas Dress, Marie C. Lin, Hsiang-Fu Kung, Feng Mao, Bing- Hua Jiang, and Lihui Lai
Multifunctional nanoparticles for targeted drug delivery and mri contrast agent
P. Pramanik
Targeting superoxide dismutase 1 for chemosensitization of platinum resistant ovarian cancer cells
Mu Wang
Unresolved inflammation: Immune dynamics of aging process and tumorigenesis
Mahin Khatami
IPMN of the pancreas - Evaluation of pathohistological subtypes and clinical outcome
Marius Distler
BiTE Antibodies for Cancer Therapy
Patrick A. Baeuerle and Roman Kischel
Mohammad Mehdi Soltan Dallal, Mohammad Hossein Yazdi, Marzieh Holakuyee, Zuhair Mohammad Hassan, Abbas Mirshafiey and Mehdi Mahdavi
Jianshi Lou, Jing Zhu and Zhiqing Cui
Miroslaw J. Szczepanski
Targeted and image-guided cancer treatment using Theranostic nanoparticles
Lily Yang
Carol Bernstein
Mutagenesis of p53 by reactive PAH and ROS
Jeffrey Field
Variability in carcinogen metabolism
Mohamadi Sarkar
Francesco Recchia
Mutagenesis as a biomarker of risk areas for carcinogens: Human biomonitoring
Vargas V M F, Coronas M V, Pereira T S, Rocha J V, Rodrigues ML, Fachel J, Faccini L S, Thiesen F, Nussbaumer L, Oliveira S Dapper V and Salvadori D M F
Carcinogenic human papillomavirus (HPV) in suburban U.S. female population
Sin Hang Lee
The tether drop hypothesis for the mechanism of chromosomal aberrations
Leon P. Bignold
Stephanos Pavlides
Qi Li
Marta Szajnik
The mechanism & causes of carcinogenesis and mutagenesis in eukaryotes
Shaukat Iqbal Malik
Gary Guishan Xiao
Katharina Pachmann
Bifidobacterium Infantis on Lewis lung cancer in mice
Hong Zhu, Zhaojun Li, Shuhua Mao, Buyun Ma, Shengtao Zhou, Licong Deng, Taiguo Liu, Dandan Cui, Yaqin Zhao, Jianping He, Cheng Yi and Ying Huang
Xu Man, Wang Yuqi, Xu Guangxu, Geng Weipu and Tang Junying
Shukla Piyush
Functional genomics to identify cancer targets
William C. Hahn
The anti-tumor role of gene UBTD1 and a positively regulatory loop between UBTD1 and p53
Xiaowei Zhang, Jin Li and Weijian Guo
R.K. Srivastava, S-N. Tang, M. Rodova, D. Nall and S. Shankar
Eldad Zacksenhaus
Lilian Jara
Pharmacogenomics predictions for breast cancer treatments efficacy and toxicity
Hugo A. Barrera-Saldana
A novel feedback loop with therapeutic implications in estrogen receptor-negative breast cancer
Ali Naderi
M. H. Bukhari
Combining biologics and cytotoxics in the treatment of inoperable cholangiocarcinoma
Lars Henrik Jensen
Stability analysis on liver cancer related miRNA in Serum
DING Xian-Feng, LI Yan and GUO Jiang-Feng
The status of anti-metastatic gene therapy in patients with advanced epithelial ovarian cancer
Samir A. Farghaly
M Ziman, M. Millward, R. Pearce, M. Lee, P. Kumarasinghe and A. Ireland
A high prevalence of metabolic syndrome in a group of colorectal patients pre surgery- A pilot study
Sissi C. Stove Lorentzen, Ingunn Bergstad, S.Gharagozlian
John E. Thompson, Catherine Taylor and Richard Dondero
The MAGE protein family: Protein degradation, genome stability, and cancer
P. Ryan Potts
GATA4 represses ERBB2 expression in cancer cells : a new tumor suppressor?
Jean IMBERT
GUC as potential DNA topoisomerase inhibitors to reduce the growth of cervical cancer cells
Hassan Hadi Abdallah, Mohammad T.M Al-dajani, Jamal Talaat, Akeem Akiboro, Khoo Boon Yin and Nornisah Mohamed
Tine D. Rasmussen, Louise Linnebjerg Bohn Christoffersen, Olaf-Georg Issinger
Yi-Ching Wang
Cancer Science & Therapy received 3968 citations as per Google Scholar report